Month: March 2022

If there were an accurate crystal ball, would you want to know your future? And if you knew something bad was going to happen, would you try to take steps to avoid it? The ancient Greek notion that you can’t escape your fate is illustrated by the tragic tale of King Oedipus, who was informed keep reading

PSMA-PET scans have become the most sensitive prostate cancer (PCa) detection for metastasis (cancer that has spread to other parts of the body), including recurrent PCa after treatment. PET uses a radioactive tracer that has been molecularly bonded with a substance readily taken up by prostate specific membrane antigen (PSMA). keep reading

If you know about metformin, a drug that is the “main first-line oral drug of choice” for type 2 diabetes patients of all agesi, you may be wondering, “Why is Dr. Sperling writing about something that has nothing to do with prostate cancer?” In fact, metformin DOES apply to prostate cancer... keep reading

Prostate cancer (PCa) is not a basic yes/no diagnosis. It would be so easy to say, “You either have it or you don’t.” If that were the case, treatment decisions would be simplified. Instead, PCa can be seen as a spectrum of diseases from precancerous conditions that can become full blown cancer, all the way keep reading

There’s an unfounded rumor floating around that Artificial Intelligence (AI) may one day replace radiologists. As a specialty field in medicine, the field is based in imaging, which allows the diagnosis and treatment of injuries and diseases. Today’s imaging techniques include X-rays, computed tomography (CT), positron emission tomography (PET), ultrasound (US) and magnetic resonance imaging keep reading

Some folks might say that ED can lead to a broken heart. On the other hand, in 1989 the physical feeling of a “broken heart” accidentally led to a treatment for ED. When pharmaceutical giant Pfizer was researching medication for angina, a painful heart condition, their researchers discovered sildenafil, now known by the brand name Viagra... keep reading

For over 75 years, testosterone replacement therapy (TRT) has been a big no-no for prostate cancer (PCa) patients. It’s unfortunate, because as men age, it’s not unusual for testosterone levels to drop, often leading to low libido, loss of muscle tone, weight gain, fatigue, and even mental/emotional changes such as depression. While PCa survivors with keep reading

The bold tag line for University College London (UCL) is “Disruptive thinking since 1826.” Back in 1826, when this global university was founded, the phrase disruptive thinking did not even exist! Today, the term disruptive permeates the worlds of industry, businesses, technology and research. Not only do disruptive innovations alter the way these fields operate, keep reading

Few medical centers are as venerable as the Mayo Clinic. It began when William Worrall Mayo, a physician and chemist, settled his family on the Minnesota prairie in 1864, and opened a small practice. His two doctor sons joined the practice. As other partners came on board, it grew into the Mayo Clinic. Today, its keep reading

These days, Active Surveillance (AS) seems to be the new best friend for prostate cancer (PCa) patients. Over 40% of newly diagnosed, low-to-favorable intermediate risk patients now begin PCa management on AS. This method defers treatment, but there’s a catch. Patients must be responsible to: Obtain the most thorough portrait of your PCa (multiparametric MRI, keep reading